The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This session discusses issues related to acute liver failure and the role that drug treatment plays in treating and dealing with acute liver issues.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/23.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: There are no disclosures to declare.
Speakers Conflict of Interest Disclosure: There are no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or corporate sponsorship was received.
Accreditation Statement: This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.
Learning Outcome: After completing this learning activity, the participant will have increased confidence in providing pharmacologic and non-pharmacologic treatment of acute liver failure.
Dianna Copley
9/30/21 6:13 pm
Awesome presentation! I see patients after transplant, helpful to have this review of what happened pre-transplant!